Concepedia

Ethan S. Sokol

ES

60

Publications

4.6K

Citations

33

H-Index

2012

Active since

Affiliations

Foundation Medicine (United States)(Current)

SUNY Upstate Medical University

Whitehead Institute for Biomedical Research

Massachusetts Institute of Technology

Harvard University

Ethan S. Sokol is an author at Foundation Medicine (United States) specializing in medicine, pathology, and oncology.

ORCID

Top concepts

Publications per year

2012–2024

60

Publications

60

Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer

Alexa B. Schrock, Ching Ouyang, Jaideep Sandhu et al. · Annals of Oncology · 2019 · 616 citations

Epithelial-to-Mesenchymal Transition Activates PERK–eIF2α and Sensitizes Cells to Endoplasmic Reticulum Stress

Yuxiong Feng, Ethan S. Sokol, Catherine Del Vecchio Fitz et al. · Cancer Discovery · 2014 · 322 citations

Microsatellite-Stable Tumors with High Mutational Burden Benefit from Immunotherapy

Aaron M. Goodman, Ethan S. Sokol, Garrett M. Frampton et al. · Cancer Immunology Research · 2019 · 308 citations

Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response

Meagan Montesion, Karthikeyan Murugesan, Dexter X. Jin et al. · Cancer Discovery · 2020 · 231 citations · Full text

Homologous Recombination Deficiency: Concepts, Definitions, and Assays

Mark Stewart, Diana Merino Vega, Rebecca C. Arend et al. · The Oncologist · 2022 · 207 citations · Full text

Rows per page

1–5 of 60